StreetInsider.com News Articles

Solventum to Report Third Quarter Fiscal 2026 Earnings on November 5, 2026

Thu, 15 Oct 2026 16:05:00 -0400

EAGAN, Minn., Oct. 15, 2026 /PRNewswire/ -- Solventum (NYSE: SOLV) will release its third quarter fiscal 2026 financial results on Thursday, November 5, 2026, after the U.S. financial markets close. Following the release, Solventum management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast.

Solventum to Report Third Quarter Fiscal 2026 Earnings on November 5, 2026

Thu, 15 Oct 2026 16:05:00 -0400

Solventum (SOLV) PT Lowered to $34 at Jefferies

Thu, 08 Oct 2026 06:09:44 -0400

Jefferies analyst Julien Dumoulin-Smith lowered the price target on Solventum (NYSE: SOLV) to $34.00 (from $43.00) while maintaining a Buy rating.

The analyst comments "Raise EBITDA ests ~7–13% as $8.9Bn backlog, project scale and fixed-price execution support further margin upside. Sector selloff disconnected from SOLV’s trajectory; peer missteps reinforce the value of proven teams. BESS and O&M broaden durability. Lower PT to $34 on de-rating, but MWH’s ~8.7x JEFe 2028 EBITDA vs EPC peers at ~12.4x offers a compelling entry point. Establish 3Q26 adj. EBITDA est $152Mn +2.7% vs cons. Reiterate Buy on core benchmark holding."

Solventum (SOLV) PT Lowered to $34 at Jefferies

Thu, 08 Oct 2026 06:09:44 -0400

Jefferies analyst Julien Dumoulin-Smith lowered the price target on Solventum (NYSE: SOLV) to $34.00 (from $43.00) while maintaining a Buy rating.

Wound Care Stocks Are Posting Double-Digit Growth. Here’s Why.

Tue, 06 Oct 2026 09:06:00 -0400

RENO, Nev., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Wall Street Investor News Commentary - The global advanced wound care market is valued at $13.37 billion in 2025 and is projected to reach $19.32 billion by 2030, a compound annual growth rate of 7.6%, according to MarketsandMarkets. The firm points to chronic disease, an aging population and traumatic injuries as the main drivers, noting that diabetic foot ulcers affect roughly a quarter of patients with diabetes and are a leading cause of hospitalization. Active Companies from around the markets with current developments this week include:

Wound Care Stocks Are Posting Double-Digit Growth. Here’s Why.

Tue, 06 Oct 2026 09:06:00 -0400

RENO, Nev., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Wall Street Investor News Commentary - The global advanced wound care market is valued at $13.37 billion in 2025 and is projected to reach $19.32 billion by 2030, a compound annual growth rate of 7.6%, according to MarketsandMarkets. The firm points to chronic disease, an aging population and traumatic injuries as the main drivers, noting that diabetic foot ulcers affect roughly a quarter of patients with diabetes and are a leading cause of hospitalization. Active Companies from around the markets with current developments this week include:

Wound Care Stocks Are Posting Double-Digit Growth. Here’s Why.

Tue, 06 Oct 2026 09:06:00 -0400

RENO, Nev., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Wall Street Investor News Commentary - The global advanced wound care market is valued at $13.37 billion in 2025 and is projected to reach $19.32 billion by 2030, a compound annual growth rate of 7.6%, according to MarketsandMarkets. The firm points to chronic disease, an aging population and traumatic injuries as the main drivers, noting that diabetic foot ulcers affect roughly a quarter of patients with diabetes and are a leading cause of hospitalization. Active Companies from around the markets with current developments this week include:

Wound Care Stocks Are Posting Double-Digit Growth. Here’s Why.

Tue, 06 Oct 2026 09:06:00 -0400

RENO, Nev., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Wall Street Investor News Commentary - The global advanced wound care market is valued at $13.37 billion in 2025 and is projected to reach $19.32 billion by 2030, a compound annual growth rate of 7.6%, according to MarketsandMarkets. The firm points to chronic disease, an aging population and traumatic injuries as the main drivers, noting that diabetic foot ulcers affect roughly a quarter of patients with diabetes and are a leading cause of hospitalization. Active Companies from around the markets with current developments this week include:

Wound Care Stocks Are Posting Double-Digit Growth. Here’s Why.

Tue, 06 Oct 2026 09:06:00 -0400

RENO, Nev., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Wall Street Investor News Commentary - The global advanced wound care market is valued at $13.37 billion in 2025 and is projected to reach $19.32 billion by 2030, a compound annual growth rate of 7.6%, according to MarketsandMarkets. The firm points to chronic disease, an aging population and traumatic injuries as the main drivers, noting that diabetic foot ulcers affect roughly a quarter of patients with diabetes and are a leading cause of hospitalization. Active Companies from around the markets with current developments this week include:

Wound Care Stocks Are Posting Double-Digit Growth. Here’s Why.

Tue, 06 Oct 2026 09:06:00 -0400

RENO, Nev., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Wall Street Investor News Commentary - The global advanced wound care market is valued at $13.37 billion in 2025 and is projected to reach $19.32 billion by 2030, a compound annual growth rate of 7.6%, according to MarketsandMarkets. The firm points to chronic disease, an aging population and traumatic injuries as the main drivers, noting that diabetic foot ulcers affect roughly a quarter of patients with diabetes and are a leading cause of hospitalization. Active Companies from around the markets with current developments this week include:

Wound Care Stocks Are Posting Double-Digit Growth. Here’s Why.

Tue, 06 Oct 2026 09:06:00 -0400

RENO, Nev., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Wall Street Investor News Commentary - The global advanced wound care market is valued at $13.37 billion in 2025 and is projected to reach $19.32 billion by 2030, a compound annual growth rate of 7.6%, according to MarketsandMarkets. The firm points to chronic disease, an aging population and traumatic injuries as the main drivers, noting that diabetic foot ulcers affect roughly a quarter of patients with diabetes and are a leading cause of hospitalization. Active Companies from around the markets with current developments this week include:

Wound Care Stocks Are Posting Double-Digit Growth. Here’s Why.

Tue, 06 Oct 2026 09:06:00 -0400

RENO, Nev., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Wall Street Investor News Commentary - The global advanced wound care market is valued at $13.37 billion in 2025 and is projected to reach $19.32 billion by 2030, a compound annual growth rate of 7.6%, according to MarketsandMarkets. The firm points to chronic disease, an aging population and traumatic injuries as the main drivers, noting that diabetic foot ulcers affect roughly a quarter of patients with diabetes and are a leading cause of hospitalization. Active Companies from around the markets with current developments this week include:

Wound Care Stocks Are Posting Double-Digit Growth. Here’s Why.

Tue, 06 Oct 2026 09:06:00 -0400

RENO, Nev., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Wall Street Investor News Commentary - The global advanced wound care market is valued at $13.37 billion in 2025 and is projected to reach $19.32 billion by 2030, a compound annual growth rate of 7.6%, according to MarketsandMarkets. The firm points to chronic disease, an aging population and traumatic injuries as the main drivers, noting that diabetic foot ulcers affect roughly a quarter of patients with diabetes and are a leading cause of hospitalization. Active Companies from around the markets with current developments this week include:

Wound Care Stocks Are Posting Double-Digit Growth. Here’s Why.

Tue, 06 Oct 2026 09:06:00 -0400

RENO, Nev., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Wall Street Investor News Commentary - The global advanced wound care market is valued at $13.37 billion in 2025 and is projected to reach $19.32 billion by 2030, a compound annual growth rate of 7.6%, according to MarketsandMarkets. The firm points to chronic disease, an aging population and traumatic injuries as the main drivers, noting that diabetic foot ulcers affect roughly a quarter of patients with diabetes and are a leading cause of hospitalization. Active Companies from around the markets with current developments this week include:

Solventum (SOLV) Reiterated at Buy by Stifel Amid SKU Growth Headwinds

Fri, 18 Sep 2026 07:47:47 -0400

Stifel analyst Rick Wise reiterated a Buy rating and $100.00 price target on Solventum (NYSE: SOLV).
The analyst commented, "Solventum's SKU program has been a growth headwind in recent years. In 2026 alone, management has indicated that the program will likely be a ~100 bps growth headwind disproportionately impacting the MedSurg division. Given all this, our updated model projects that MedSurg 2027 organic growth moves higher to +3.4% versus the +1.6% assumed previously. Turning to gross margin, we re-phased our quarterly estimates to reflect 3M supply agreement pricing mark-ups (i.e., contractual price mark-ups Solventum pays 3M for products/inputs), landing in 2H27

Form 4 Solventum Corp For: Sep 01 Filed by: Hanson Bryan C

Thu, 03 Sep 2026 16:11:00 -0400
si-local-file:///var/storage/secattach/20260903/27025118.html

Form 4 Solventum Corp For: Sep 01 Filed by: Hanson Bryan C

Thu, 03 Sep 2026 16:11:00 -0400
si-local-file:///var/storage/secattach/20260903/27025118.html

Solventum to Participate in the 2026 Wells Fargo Healthcare Conference

Wed, 02 Sep 2026 16:05:00 -0400

EAGAN, Minn., Sept. 2, 2026 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that management will participate in a fireside chat at the Wells Fargo Healthcare Conference on Wednesday, Sept. 9, 2026, beginning at approximately 10:15 a.m. EDT in Boston, MA.

Solventum to Participate in the 2026 Wells Fargo Healthcare Conference

Wed, 02 Sep 2026 16:05:00 -0400

EAGAN, Minn., Sept. 2, 2026 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that management will participate in a fireside chat at the Wells Fargo Healthcare Conference on Wednesday, Sept. 9, 2026, beginning at approximately 10:15 a.m. EDT in Boston, MA.

Form 4 Solventum Corp For: Aug 17 Filed by: Zieselman Neil Craig

Tue, 18 Aug 2026 16:11:00 -0400
si-local-file:///var/storage/secattach/20260818/26944325.html

Form 4 Solventum Corp For: Aug 17 Filed by: Zieselman Neil Craig

Tue, 18 Aug 2026 16:11:00 -0400
si-local-file:///var/storage/secattach/20260818/26944325.html

Form 4 Solventum Corp For: Aug 17 Filed by: Zieselman Neil Craig

Tue, 18 Aug 2026 16:11:00 -0400
si-local-file:///var/storage/secattach/20260818/26944325.html

Form 3 Solventum Corp For: Aug 10 Filed by: Zieselman Neil Craig

Tue, 18 Aug 2026 16:08:00 -0400
si-local-file:///var/storage/secattach/20260818/26944258.html

Form 3 Solventum Corp For: Aug 10 Filed by: Zieselman Neil Craig

Tue, 18 Aug 2026 16:08:00 -0400
si-local-file:///var/storage/secattach/20260818/26944258.html

Form 3 Solventum Corp For: Aug 10 Filed by: Zieselman Neil Craig

Tue, 18 Aug 2026 16:08:00 -0400
si-local-file:///var/storage/secattach/20260818/26944258.html